Performance Measurement of Medicines Delivery of Pharmaceutical Companies Under Chain of Sustainable Procurement

Performance Measurement of Medicines Delivery of Pharmaceutical Companies Under Chain of Sustainable Procurement

Kaminee Sahu (PhD Research Scholar, Pharmacy Department, Bhagwant University, Ajmer, India) and Anoop Kumar Sahu (Department of Mechanical Engg, Madanapalle Institute of Technology and Science, Andhra Pradesh, India)
DOI: 10.4018/IJSESD.2019070108
OnDemand PDF Download:
No Current Special Offers


Pharmaceuticals companies manufacture and maintain the stocks of several medicines. Presently, hospitals maintain stock to supply the appropriate medicine to patients under their care. The availability of medicines is dependent on the service level of suppliers. In last decade, the pharmaceutical supply chains have been an increasingly important topic. Pharmaceutical supply chains of the medicine manufacturing firm are based on traditional supply chain strategies. But, the concept became obsolete, replaced by modern supply chain strategy. The modern supply chain better analyzes pharmaceutical architectures such as green, service, agile, resilient, flexible manufacturing and is called the pharmaceutical G-F-A-L-R supply chain. To evolve a new model for the pharmaceutical supply chain, a 2nd second level pharmaceutical hierarchy G-F-A-L-R supply chain module structure has been constructed, where a Fuzzy Performance Index model has been applied on the module to compute the overall performance of individual pharmaceutical companies.
Article Preview

1. Introduction

The pharmaceutical industries search, build, produces, and markets the drugs or pharmaceutical medicines for use as medications. Pharmaceutical companies deal with a generic or brand medications and medical devices. Pharmaceutical Companies are the considered as manufactures and delivers the medicines at right time in world.

The supply chain is one of the most compound network in the world. It is seen as significant supplier to retailer network, which replies to supply drugs to pharmaceutical companies’ partners Baporikar (2017), Juliani et al, (2017), Ocampo and & Clark (2017), Rahmayanti & Ananda (2017). Recently a topic is called as pharmaceuticals supply chain received the attention from researchers due to escalation in the pollution of hospitals. The performance of pharmaceutical companies was mapped based on traditional supply chain strategy in last decade. Supply Chain Management (SCM) is described as the procedure of planning and executing, and at the same time managing the supply chain by the mainly efficient potential way. Supply chain management involves controlling of finished products from the source of origin the consumption level. Green supply chain refers to the implementation of an environmental moral and thinking at each instance of the traditional SC system. After traditional supply chain, many moderns supply chain strategies were developed, which are below:

Green supply chain is considered as a means to drive out the unwanted and undesirable pollutions e.g. ill-biological particles, fossil fuel, hazard particle, ill-particles, toxic gasses etc. from each subsystem/agents of traditional SC circuit.

Supply chain flexibility is extensively measured as one of the major response to the increasing uncertainty and competition in the marketplace. With global competition rapidly intensifying and shifting to the supply chain level, supply chain flexibility has become increasingly important.

Agile supply chain deals with alters in dissimilar facets i.e. alter in customer demands, scientific advancements and unbalanced business environment

The Lean supply chain is a team-based approach to nonstop upgrading technologies/ approaches / paths towards reducing the unworthily added activities or waste from the perspective of the clients. Resilience supply chain is connected to both the individual and organizational answerable to turbulence and discontinuities. This requirement to introduce all the strategies under concerns of green, service, agile, resilient, flexible pharmaceutical supply chain is called as G-F-A-L-R pharmaceutical supply chain. To evolving the model under proposed new G-F-A-L-R pharmaceutical supply chain, the authors conduct the further literature survey. Figure 1 has shown the G-F-A-L-R pharmaceutical supply chain.

Figure 1.

G-F-A-L-R pharmaceutical supply chain


Complete Article List

Search this Journal:
Open Access Articles
Volume 13: 6 Issues (2022): 1 Released, 5 Forthcoming
Volume 12: 4 Issues (2021): 3 Released, 1 Forthcoming
Volume 11: 4 Issues (2020)
Volume 10: 4 Issues (2019)
Volume 9: 4 Issues (2018)
Volume 8: 4 Issues (2017)
Volume 7: 4 Issues (2016)
Volume 6: 4 Issues (2015)
Volume 5: 4 Issues (2014)
Volume 4: 4 Issues (2013)
Volume 3: 4 Issues (2012)
Volume 2: 4 Issues (2011)
Volume 1: 4 Issues (2010)
View Complete Journal Contents Listing